» Articles » PMID: 34135556

Requirements for Implementation of Artificial Intelligence in the Practice of Gastrointestinal Pathology

Overview
Specialty Gastroenterology
Date 2021 Jun 17
PMID 34135556
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Tremendous advances in artificial intelligence (AI) in medical image analysis have been achieved in recent years. The integration of AI is expected to cause a revolution in various areas of medicine, including gastrointestinal (GI) pathology. Currently, deep learning algorithms have shown promising benefits in areas of diagnostic histopathology, such as tumor identification, classification, prognosis prediction, and biomarker/genetic alteration prediction. While AI cannot substitute pathologists, carefully constructed AI applications may increase workforce productivity and diagnostic accuracy in pathology practice. Regardless of these promising advances, unlike the areas of radiology or cardiology imaging, no histopathology-based AI application has been approved by a regulatory authority or for public reimbursement. Thus, implying that there are still some obstacles to be overcome before AI applications can be safely and effectively implemented in real-life pathology practice. The challenges have been identified at different stages of the development process, such as needs identification, data curation, model development, validation, regulation, modification of daily workflow, and cost-effectiveness balance. The aim of this review is to present challenges in the process of AI development, validation, and regulation that should be overcome for its implementation in real-life GI pathology practice.

Citing Articles

Deep learning framework for comprehensive molecular and prognostic stratifications of triple-negative breast cancer.

Zhao S, Yan C, Lv H, Yang J, You C, Li Z Fundam Res. 2024; 4(3):678-689.

PMID: 38933195 PMC: 11197495. DOI: 10.1016/j.fmre.2022.06.008.


Evaluating Cellularity Estimation Methods: Comparing AI Counting with Pathologists' Visual Estimates.

Kiyuna T, Cosatto E, Hatanaka K, Yokose T, Tsuta K, Motoi N Diagnostics (Basel). 2024; 14(11).

PMID: 38893641 PMC: 11171606. DOI: 10.3390/diagnostics14111115.


An Intelligent Search & Retrieval System (IRIS) and Clinical and Research Repository for Decision Support Based on Machine Learning and Joint Kernel-based Supervised Hashing.

Foran D, Chen W, Kurc T, Gupta R, Kaczmarzyk J, Torre-Healy L Cancer Inform. 2024; 23:11769351231223806.

PMID: 38322427 PMC: 10840403. DOI: 10.1177/11769351231223806.


Artificial intelligence in diagnostic pathology.

Shafi S, Parwani A Diagn Pathol. 2023; 18(1):109.

PMID: 37784122 PMC: 10546747. DOI: 10.1186/s13000-023-01375-z.


Molecular Classifiers in Skin Cancers: Challenges and Promises.

Azimi A, Fernandez-Penas P Cancers (Basel). 2023; 15(18).

PMID: 37760432 PMC: 10526380. DOI: 10.3390/cancers15184463.


References
1.
Courtiol P, Maussion C, Moarii M, Pronier E, Pilcer S, Sefta M . Deep learning-based classification of mesothelioma improves prediction of patient outcome. Nat Med. 2019; 25(10):1519-1525. DOI: 10.1038/s41591-019-0583-3. View

2.
Korbar B, Olofson A, Miraflor A, Nicka C, Suriawinata M, Torresani L . Deep Learning for Classification of Colorectal Polyps on Whole-slide Images. J Pathol Inform. 2017; 8:30. PMC: 5545773. DOI: 10.4103/jpi.jpi_34_17. View

3.
Niu P, Zhao L, Wu H, Zhao D, Chen Y . Artificial intelligence in gastric cancer: Application and future perspectives. World J Gastroenterol. 2020; 26(36):5408-5419. PMC: 7520602. DOI: 10.3748/wjg.v26.i36.5408. View

4.
Shapcott M, Hewitt K, Rajpoot N . Deep Learning With Sampling in Colon Cancer Histology. Front Bioeng Biotechnol. 2019; 7:52. PMC: 6445856. DOI: 10.3389/fbioe.2019.00052. View

5.
Wei J, Suriawinata A, Vaickus L, Ren B, Liu X, Lisovsky M . Evaluation of a Deep Neural Network for Automated Classification of Colorectal Polyps on Histopathologic Slides. JAMA Netw Open. 2020; 3(4):e203398. PMC: 7180424. DOI: 10.1001/jamanetworkopen.2020.3398. View